-
1
-
-
3142735150
-
Pre-emptive gene therapy using recombinant adenoassociated virus delivery of extracellular superoxide dismutase protects heart against ischemic reperfusion injury, improves ventricular function and prolongs survival
-
Agrawal, R.S., Muangman, S., Layne, M.D., Melo, L., Perrella, M.A., Lee, R.T., Hang, L., Lopez-Ilasaca, M., and Dzau, V.J. (2004) Pre-emptive gene therapy using recombinant adenoassociated virus delivery of extracellular superoxide dismutase protects heart against ischemic reperfusion injury, improves ventricular function and prolongs survival. Gene Ther., 11: 962-969.
-
(2004)
Gene Ther.
, vol.11
, pp. 962-969
-
-
Agrawal, R.S.1
Muangman, S.2
Layne, M.D.3
Melo, L.4
Perrella, M.A.5
Lee, R.T.6
Hang, L.7
Lopez-Ilasaca, M.8
Dzau, V.J.9
-
2
-
-
0032548835
-
Vascular endothelial growth factor induces heparin-binding epidermal growth factor-like growth factor in vascular endothelial cells
-
Arkonac, B.M., Foster, L.C., Sibinga, N.E., Patterson, C., Lai, K., Tsai, J.C., Lee, M.E., Perrella, M.A., and Haber, E. (1998) Vascular endothelial growth factor induces heparin-binding epidermal growth factor-like growth factor in vascular endothelial cells. J. Biol. Chem., 273: 4400-4405.
-
(1998)
J. Biol. Chem.
, vol.273
, pp. 4400-4405
-
-
Arkonac, B.M.1
Foster, L.C.2
Sibinga, N.E.3
Patterson, C.4
Lai, K.5
Tsai, J.C.6
Lee, M.E.7
Perrella, M.A.8
Haber, E.9
-
3
-
-
0037689525
-
Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors
-
Arsic, N., Zentilin, L., Zacchigna, S., Santoro, D., Stanta, G., Salvi, A., Sinagra, G., and Giacca, M. (2003) Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors. Mol. Ther., 7: 450-459.
-
(2003)
Mol. Ther.
, vol.7
, pp. 450-459
-
-
Arsic, N.1
Zentilin, L.2
Zacchigna, S.3
Santoro, D.4
Stanta, G.5
Salvi, A.6
Sinagra, G.7
Giacca, M.8
-
4
-
-
2642526164
-
VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model
-
Azzouz, M., Ralph, G.S., Storkerbaum, E., Walmsley, L.E., Mitrophanous, K.A., Kingsman, S.M., Carmeliet, P., and Mazarakis, N.D. (2004) VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature, 429: 413-417.
-
(2004)
Nature
, vol.429
, pp. 413-417
-
-
Azzouz, M.1
Ralph, G.S.2
Storkerbaum, E.3
Walmsley, L.E.4
Mitrophanous, K.A.5
Kingsman, S.M.6
Carmeliet, P.7
Mazarakis, N.D.8
-
5
-
-
12744272136
-
Cell-selective viral gene delivery vectors for the vasculature
-
Baker, A.H., Kritz, A., Work, L.M., and Nicklin, S.A. (2005) Cell-selective viral gene delivery vectors for the vasculature. Exp. Physiol., 90: 27-31.
-
(2005)
Exp. Physiol.
, vol.90
, pp. 27-31
-
-
Baker, A.H.1
Kritz, A.2
Work, L.M.3
Nicklin, S.A.4
-
6
-
-
0033007934
-
Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'gamma)2 antibody
-
Bartlett, J.S., Kleinschmidt, J., Boucher, R.C., and Samulski, R.J. (1999) Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'gamma)2 antibody. Nat. Biotechnol., 17: 181-186.
-
(1999)
Nat. Biotechnol.
, vol.17
, pp. 181-186
-
-
Bartlett, J.S.1
Kleinschmidt, J.2
Boucher, R.C.3
Samulski, R.J.4
-
7
-
-
4644252083
-
Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6
-
Blankinship, M.J., Gregorevic, P., Allen, J.M., Harper, S.Q., Harper, H., Halbert, C.L., Miller, D.A., and Chamberlain, J.S. (2004) Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6. Mol. Ther., 10: 671-678.
-
(2004)
Mol. Ther.
, vol.10
, pp. 671-678
-
-
Blankinship, M.J.1
Gregorevic, P.2
Allen, J.M.3
Harper, S.Q.4
Harper, H.5
Halbert, C.L.6
Miller, D.A.7
Chamberlain, J.S.8
-
8
-
-
0035038918
-
The well-tempered vessel
-
Blau, H. M., and Banfi, A. (2001) The well-tempered vessel. Nat. Med., 7: 532-534.
-
(2001)
Nat. Med.
, vol.7
, pp. 532-534
-
-
Blau, H.M.1
Banfi, A.2
-
9
-
-
0242637112
-
Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): Mechanistic insights from serial contrast-enhanced magnetic resonance imaging
-
Britten, M.B., Abolmaali, N.D., Assmus, B., Lehmann, R., Honold, J., Schmitt, J., Vogl, T.J., Martin, H., Schachinger, V., Dimmeler, S., and Zeiher, A.M. (2003) Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation, 108: 2212-2218.
-
(2003)
Circulation
, vol.108
, pp. 2212-2218
-
-
Britten, M.B.1
Abolmaali, N.D.2
Assmus, B.3
Lehmann, R.4
Honold, J.5
Schmitt, J.6
Vogl, T.J.7
Martin, H.8
Schachinger, V.9
Dimmeler, S.10
Zeiher, A.M.11
-
10
-
-
0042827473
-
AAV-based gene transfer
-
Buning, H., Nicklin, S.A., Perabo, L., Hallek, M., and Baker, A.H. (2003) AAV-based gene transfer. Curr. Opin. Mol. Ther., 5: 367-375.
-
(2003)
Curr. Opin. Mol. Ther.
, vol.5
, pp. 367-375
-
-
Buning, H.1
Nicklin, S.A.2
Perabo, L.3
Hallek, M.4
Baker, A.H.5
-
11
-
-
3542999278
-
VEGF links hippocampal activity with neurogenesis, learning and memory
-
Cao, L., Jiao, X., Zuzga, D.S., Liu, Y., Fong, D.M., Young, D., and During, M.J. (2004) VEGF links hippocampal activity with neurogenesis, learning and memory. Nat. Genet., 36: 827-835.
-
(2004)
Nat. Genet.
, vol.36
, pp. 827-835
-
-
Cao, L.1
Jiao, X.2
Zuzga, D.S.3
Liu, Y.4
Fong, D.M.5
Young, D.6
During, M.J.7
-
12
-
-
12344261807
-
Update on therapeutic neovascularization
-
Cao, Y., Hong, A., Schulten, H., and Post, M.J. (2005) Update on therapeutic neovascularization. Cardiovasc. Res., 65: 639-648.
-
(2005)
Cardiovasc. Res.
, vol.65
, pp. 639-648
-
-
Cao, Y.1
Hong, A.2
Schulten, H.3
Post, M.J.4
-
13
-
-
0038363443
-
Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2
-
Cao, R., Brakenhielm, E., Pawliuk, R., Wariaro, D., Post, M.J., Wahlberg, E., Leboulch, P., and Cao, Y. (2003) Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat. Med., 9: 604-613.
-
(2003)
Nat. Med.
, vol.9
, pp. 604-613
-
-
Cao, R.1
Brakenhielm, E.2
Pawliuk, R.3
Wariaro, D.4
Post, M.J.5
Wahlberg, E.6
Leboulch, P.7
Cao, Y.8
-
14
-
-
10944271807
-
Efficacy of gene therapy for SCID is being confirmed
-
Cavazzana-Calvo, M., and Fischer, A. (2004) Efficacy of gene therapy for SCID is being confirmed. Lancet, 364: 2155-2156.
-
(2004)
Lancet
, vol.364
, pp. 2155-2156
-
-
Cavazzana-Calvo, M.1
Fischer, A.2
-
15
-
-
0034724857
-
Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
-
Cavazzana-Calvo, M., Hacein-Bey, S., de Saint Basile, G., Gross, F., Yvon, E., Nusbaum, P., Selz, F., Hue, C., Certain, S., Casanova, J.L., Bousso, P., Deist, F.L., and Fischer A. (2000) Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science, 288: 669-672.
-
(2000)
Science
, vol.288
, pp. 669-672
-
-
Cavazzana-Calvo, M.1
Hacein-Bey, S.2
de Saint Basile, G.3
Gross, F.4
Yvon, E.5
Nusbaum, P.6
Selz, F.7
Hue, C.8
Certain, S.9
Casanova, J.L.10
Bousso, P.11
Deist, F.L.12
Fischer, A.13
-
16
-
-
14544269487
-
Gene therapy for severe combined immunodeficiency
-
Cavazzana-Calvo, M., Lagresle, C., Hacein-Bey-Abina, S., and Fischer, A. (2005) Gene therapy for severe combined immunodeficiency. Annu. Rev. Med., 56: 585-602.
-
(2005)
Annu. Rev. Med.
, vol.56
, pp. 585-602
-
-
Cavazzana-Calvo, M.1
Lagresle, C.2
Hacein-Bey-Abina, S.3
Fischer, A.4
-
17
-
-
32944459983
-
Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain
-
Cearley, C.N., and Wolfe, J.H. (2006) Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain. Mol. Ther., 13: 528-537.
-
(2006)
Mol. Ther.
, vol.13
, pp. 528-537
-
-
Cearley, C.N.1
Wolfe, J.H.2
-
18
-
-
0034572459
-
Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors
-
Chao, H., Liu, Y., Rabinowitz, J., Li, C., Samulski, R.J., and Walsh, C.E. (2000) Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors. Mol. Ther., 2: 619-623.
-
(2000)
Mol. Ther.
, vol.2
, pp. 619-623
-
-
Chao, H.1
Liu, Y.2
Rabinowitz, J.3
Li, C.4
Samulski, R.J.5
Walsh, C.E.6
-
19
-
-
0034842912
-
Sustained and complete phenotype correction of hemophilia B mice following intramuscular injection of AAV1 serotype vectors
-
Chao, H., Monahan, P.E., Liu, Y., Samulski, R.J., and Walsh, C.E. (2001) Sustained and complete phenotype correction of hemophilia B mice following intramuscular injection of AAV1 serotype vectors. Mol. Ther., 4: 217-222.
-
(2001)
Mol. Ther.
, vol.4
, pp. 217-222
-
-
Chao, H.1
Monahan, P.E.2
Liu, Y.3
Samulski, R.J.4
Walsh, C.E.5
-
20
-
-
20044374997
-
Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectors
-
Chen, S., Kapturczak, M., Loiler, S.A., Zolotukhin, S., Glushakova, O.Y., Madsen, K.M., Samulski, R.J., Hauswirth, W.W., Campbell-Thompson, M., Berns, K.I., Flotte, T.R., Atkinson, M.A., Tischer, C.C., Agarwal, A. (2005). Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectors. Hum. Gene Ther., 16: 235-47.
-
(2005)
Hum. Gene Ther.
, vol.16
, pp. 235-247
-
-
Chen, S.1
Kapturczak, M.2
Loiler, S.A.3
Zolotukhin, S.4
Glushakova, O.Y.5
Madsen, K.M.6
Samulski, R.J.7
Hauswirth, W.W.8
Campbell-Thompson, M.9
Berns, K.I.10
Flotte, T.R.11
Atkinson, M.A.12
Tischer, C.C.13
Agarwal, A.14
-
21
-
-
10344226206
-
Augmentation of therapeutic angiogenesis using genetically modified human endothelial progenitor cells with altered glycogen synthase kinase-3beta activity
-
Choi, J.H., Hur, J., Yoon, C.H., Kim, J.H., Lee, C.S., Youn, S.W., Oh, I.Y., Skurk, C., Murohara, T., Park, Y.B., Walsh, K., and Kim, H.S. (2004) Augmentation of therapeutic angiogenesis using genetically modified human endothelial progenitor cells with altered glycogen synthase kinase-3beta activity. J. Biol. Chem., 279: 49430-49438.
-
(2004)
J. Biol. Chem.
, vol.279
, pp. 49430-49438
-
-
Choi, J.H.1
Hur, J.2
Yoon, C.H.3
Kim, J.H.4
Lee, C.S.5
Youn, S.W.6
Oh, I.Y.7
Skurk, C.8
Murohara, T.9
Park, Y.B.10
Walsh, K.11
Kim, H.S.12
-
22
-
-
21244491577
-
AAV hybrid serotypes: Improved vectors for gene delivery
-
Choi, V.W., McCarty, D.M., and Samulski, R.J. (2005) AAV hybrid serotypes: improved vectors for gene delivery. Curr. Gene Ther., 5: 299-310.
-
(2005)
Curr. Gene Ther.
, vol.5
, pp. 299-310
-
-
Choi, V.W.1
McCarty, D.M.2
Samulski, R.J.3
-
23
-
-
13944278472
-
Gene therapy. As Gelsinger case ends, gene therapy suffers another blow
-
Couzin, J., and Kaiser, J. (2005) Gene therapy. As Gelsinger case ends, gene therapy suffers another blow. Science, 307:1028.
-
(2005)
Science
, vol.307
, pp. 1028
-
-
Couzin, J.1
Kaiser, J.2
-
24
-
-
0026081764
-
Correction of ADA deficiency in human T lymphocytes using retroviral-mediated gene transfer
-
Culver, K.W., Osborne, W.R., Miller, A.D., Fleisher, T.A., Berger, M., Anderson, W.F., and Blaese, R.M. (1991) Correction of ADA deficiency in human T lymphocytes using retroviral-mediated gene transfer. Transplant. Proc., 23: 170-171.
-
(1991)
Transplant. Proc.
, vol.23
, pp. 170-171
-
-
Culver, K.W.1
Osborne, W.R.2
Miller, A.D.3
Fleisher, T.A.4
Berger, M.5
Anderson, W.F.6
Blaese, R.M.7
-
25
-
-
0027312173
-
Molecular adaptation of cellular defences following preconditioning of the heart by repeated ischemia
-
Das, D.K., Engelman, R.M., and Kimura, Y. (1993) Molecular adaptation of cellular defences following preconditioning of the heart by repeated ischemia. Cardiovasc. Res., 27: 578-84.
-
(1993)
Cardiovasc. Res.
, vol.27
, pp. 578-584
-
-
Das, D.K.1
Engelman, R.M.2
Kimura, Y.3
-
26
-
-
0034724209
-
Recombinant adeno-associated virus type 2, 4, and 5 vectors: Transduction of variant cell types and regions in the mammalian central nervous system
-
Davidson, B., Stein, C., Heth, J., Martins, I., Kotin, R.M., Derksen, T.A., Zabner, J., Ghodsi, A., and Chiorini, J.A. (2000) Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc. Natl. Acad. Sci. USA, 97: 3428-3432.
-
(2000)
Proc. Natl. Acad. Sci. USA
, vol.97
, pp. 3428-3432
-
-
Davidson, B.1
Stein, C.2
Heth, J.3
Martins, I.4
Kotin, R.M.5
Derksen, T.A.6
Zabner, J.7
Ghodsi, A.8
Chiorini, J.A.9
-
27
-
-
27144473384
-
Adeno-associated virus (AAV)-7 and -8 poorly transduce vascular endothelial cells and are sensitive to proteasomal degradation
-
Denby, L., Nicklin, S.A., and Baker, A.H. (2005) Adeno-associated virus (AAV)-7 and -8 poorly transduce vascular endothelial cells and are sensitive to proteasomal degradation. Gene Ther., 12: 1534-1538.
-
(2005)
Gene Ther.
, vol.12
, pp. 1534-1538
-
-
Denby, L.1
Nicklin, S.A.2
Baker, A.H.3
-
28
-
-
33644862630
-
H11 kinase prevents myocardial infarction by preemptive preconditioning of the heart
-
Depre, C., Wang, L., Sui, X., Qiu, H., Hong, C., Hedhli, N., Ginion, A., Shah, A., Pelat, M., Bertrand, L., Wagner, T., Gaussin, V., and Vatner, S.F. (2006) H11 kinase prevents myocardial infarction by preemptive preconditioning of the heart. Circ. Res., 98: 280-288.
-
(2006)
Circ. Res.
, vol.98
, pp. 280-288
-
-
Depre, C.1
Wang, L.2
Sui, X.3
Qiu, H.4
Hong, C.5
Hedhli, N.6
Ginion, A.7
Shah, A.8
Pelat, M.9
Bertrand, L.10
Wagner, T.11
Gaussin, V.12
Vatner, S.F.13
-
29
-
-
5344229985
-
Anti-oxidative stress-associated genes in circulating progenitor cells: Evidence for enhanced resistance against oxidative stress
-
Dernbach, E., Urbich, C., Brandes, R.P., Hofmann, W.K., Zeiher, A.M., and Dimmeler, S. (2004) Anti-oxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress. Blood, 104: 3591-3597.
-
(2004)
Blood
, vol.104
, pp. 3591-3597
-
-
Dernbach, E.1
Urbich, C.2
Brandes, R.P.3
Hofmann, W.K.4
Zeiher, A.M.5
Dimmeler, S.6
-
30
-
-
0037090776
-
Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy
-
Dor, Y., Djonov, V., Abramovitch, R., Itin, A., Fishman, G. I., Carmeliet, P., Goelman, G., and Keshet, E. (2002) Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy. EMBO J., 21: 1939-1947.
-
(2002)
EMBO J.
, vol.21
, pp. 1939-1947
-
-
Dor, Y.1
Djonov, V.2
Abramovitch, R.3
Itin, A.4
Fishman, G.I.5
Carmeliet, P.6
Goelman, G.7
Keshet, E.8
-
31
-
-
0037002770
-
Gene transfer of naked vegf plasmid induces the formation of microvessels but not mature collaterals in ischemic limb muscles
-
Dulak, J., Partyka, L., Jozkowicz, A., Heba, G., Prager, M., Neumayer, C., Sobhian, B., Thurner, M., Nanobashvili, J., Fuegl, A., Ratajska, A., Polterauer, P., Pachinger, O., Weidinger, F., Dembinska-Kiec, A., Redl, H., and Huk, I. (2002). Gene transfer of naked vegf plasmid induces the formation of microvessels but not mature collaterals in ischemic limb muscles, Eur. Surg., 34: 105-110.
-
(2002)
Eur. Surg.
, vol.34
, pp. 105-110
-
-
Dulak, J.1
Partyka, L.2
Jozkowicz, A.3
Heba, G.4
Prager, M.5
Neumayer, C.6
Sobhian, B.7
Thurner, M.8
Nanobashvili, J.9
Fuegl, A.10
Ratajska, A.11
Polterauer, P.12
Pachinger, O.13
Weidinger, F.14
Dembinska-Kiec, A.15
Redl, H.16
Huk, I.17
-
32
-
-
30744457050
-
New strategies for cardiovascular gene therapy: Regulatable pre-emptive expression of pro-angiogenic and antioxidant genes
-
Dulak, J., Zagorska, A., Wegiel, B., Loboda, A., and Jozkowicz, A. (2006) New strategies for cardiovascular gene therapy: regulatable pre-emptive expression of pro-angiogenic and antioxidant genes. Cell. Biochem. Biophys., 44: 31-42.
-
(2006)
Cell. Biochem. Biophys.
, vol.44
, pp. 31-42
-
-
Dulak, J.1
Zagorska, A.2
Wegiel, B.3
Loboda, A.4
Jozkowicz, A.5
-
33
-
-
4444370799
-
Gene therapy clinical trials worldwide 1989-2004 - An overview
-
Edelstein, M.L., Abedi, M.R., Wixon, J., and Edelstein, R.M. (2004) Gene therapy clinical trials worldwide 1989-2004 - an overview. J. Gene Med., 6: 597-602.
-
(2004)
J. Gene Med.
, vol.6
, pp. 597-602
-
-
Edelstein, M.L.1
Abedi, M.R.2
Wixon, J.3
Edelstein, R.M.4
-
34
-
-
33745954427
-
Cardiomyocyte-specific overexpression of NO synthase-3 protects against myocardial ischemia-reperfusion injury
-
Elrod, J.W., Greer, J.J., Bryan, N.S., Langston, W., Szot, J.F., Gebregzlabher, H., Janssens, S., Feelisch, M., and Lefer, D.J. (2006) Cardiomyocyte-specific overexpression of NO synthase-3 protects against myocardial ischemia-reperfusion injury. Arterioscler. Thromb. Vasc. Biol., 26: 1517-1523.
-
(2006)
Arterioscler. Thromb. Vasc. Biol.
, vol.26
, pp. 1517-1523
-
-
Elrod, J.W.1
Greer, J.J.2
Bryan, N.S.3
Langston, W.4
Szot, J.F.5
Gebregzlabher, H.6
Janssens, S.7
Feelisch, M.8
Lefer, D.J.9
-
35
-
-
0035830441
-
Local delivery of human tissue kallikrein gene accelerates spontaneous angiogenesis in mouse model of hindlimb ischemia
-
Emanueli, C., Minasi, A., Zacheo, A., Chao, J., Chao, L., Salis, M.B., Straino, S., Gozzi, M.G., Smith, R., Gaspa, L., Bianchini, G., Stillo, F., Capogrossi, M.C., and Madeddu, P. (2001) Local delivery of human tissue kallikrein gene accelerates spontaneous angiogenesis in mouse model of hindlimb ischemia. Circulation, 103: 125-132.
-
(2001)
Circulation
, vol.103
, pp. 125-132
-
-
Emanueli, C.1
Minasi, A.2
Zacheo, A.3
Chao, J.4
Chao, L.5
Salis, M.B.6
Straino, S.7
Gozzi, M.G.8
Smith, R.9
Gaspa, L.10
Bianchini, G.11
Stillo, F.12
Capogrossi, M.C.13
Madeddu, P.14
-
36
-
-
0037159284
-
Nerve growth factor promotes angiogenesis and arteriogenesis in ischemic hindlimbs
-
Emanueli, C., Salis, M.B., Pinna, A., Graiani, G., Manni, L., and Madeddu, P. (2002) Nerve growth factor promotes angiogenesis and arteriogenesis in ischemic hindlimbs. Circulation, 106: 2257-2262.
-
(2002)
Circulation
, vol.106
, pp. 2257-2262
-
-
Emanueli, C.1
Salis, M.B.2
Pinna, A.3
Graiani, G.4
Manni, L.5
Madeddu, P.6
-
37
-
-
20844448566
-
Akt/protein kinase B and endothelial nitric oxide synthase mediate muscular neovascularization induced by tissue kallikrein gene transfer
-
Emanueli C, Salis MB, Van Linthout S, Meloni M, Desortes E, Silvestre JS, Clergue M, Figueroa CD, Gadau S, Condorelli G, and Madeddu, P. (2004) Akt/protein kinase B and endothelial nitric oxide synthase mediate muscular neovascularization induced by tissue kallikrein gene transfer. Circulation, 110: 1638-1644.
-
(2004)
Circulation
, vol.110
, pp. 1638-1644
-
-
Emanueli, C.1
Salis, M.B.2
Van Linthout, S.3
Meloni, M.4
Desortes, E.5
Silvestre, J.S.6
Clergue, M.7
Figueroa, C.D.8
Gadau, S.9
Condorelli, G.10
Madeddu, P.11
-
38
-
-
0033758642
-
Adenovirus-mediated human tissue kallikrein gene delivery induces angiogenesis in normoperfused skeletal muscle
-
Emanueli, C., Zacheo, A., Minasi, A, Chao, J., Chao, L., Salis, M.B., Stacca, T., Straino, S., Capogrossi, M.C., and Madeddu, P. (2000) Adenovirus-mediated human tissue kallikrein gene delivery induces angiogenesis in normoperfused skeletal muscle. Arterioscler. Thromb. Vasc. Biol., 20: 2379-2385.
-
(2000)
Arterioscler. Thromb. Vasc. Biol.
, vol.20
, pp. 2379-2385
-
-
Emanueli, C.1
Zacheo, A.2
Minasi, A.3
Chao, J.4
Chao, L.5
Salis, M.B.6
Stacca, T.7
Straino, S.8
Capogrossi, M.C.9
Madeddu, P.10
-
39
-
-
0345411588
-
Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV)
-
Erles, K., Sebokova, P., and Schlehofer, J. R. (1999) Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV). J. Med. Virol., 59: 406-411.
-
(1999)
J. Med. Virol.
, vol.59
, pp. 406-411
-
-
Erles, K.1
Sebokova, P.2
Schlehofer, J.R.3
-
40
-
-
0036084994
-
Cellular glutathione peroxidase deficiency and endothelial dysfunction
-
Forgione, M.A., Weiss, N., Heydrick, S., Cap, A., Klings, E.S., Bierl, C., Eberhardt, R.T., Farber, H.W., and Loscalzo, J. (2002) Cellular glutathione peroxidase deficiency and endothelial dysfunction. Am. J. Physiol. Heart Circ. Physiol., 282: H1255-1261.
-
(2002)
Am. J. Physiol. Heart Circ. Physiol.
, vol.282
-
-
Forgione, M.A.1
Weiss, N.2
Heydrick, S.3
Cap, A.4
Klings, E.S.5
Bierl, C.6
Eberhardt, R.T.7
Farber, H.W.8
Loscalzo, J.9
-
41
-
-
0036137469
-
Therapeutic angiogenesis for coronary artery disease
-
Freedman, S.B., and Isner, J.M. (2002) Therapeutic angiogenesis for coronary artery disease. Ann. Intern. Med., 1: 54-71.
-
(2002)
Ann. Intern. Med.
, vol.1
, pp. 54-71
-
-
Freedman, S.B.1
Isner, J.M.2
-
42
-
-
33644866801
-
Impaired angiogenesis in glutathione peroxidase-1-deficient mice is associated with endothelial progenitor cell dysfunction
-
Galasso, G., Schiekofer, S., Sato, K., Shibata, R., Handy, D.E., Ouchi, N., Leopold, J.A., Loscalzo, J., and Walsh, K. (2006) Impaired angiogenesis in glutathione peroxidase-1-deficient mice is associated with endothelial progenitor cell dysfunction. Circ. Res., 98: 254-261.
-
(2006)
Circ. Res.
, vol.98
, pp. 254-261
-
-
Galasso, G.1
Schiekofer, S.2
Sato, K.3
Shibata, R.4
Handy, D.E.5
Ouchi, N.6
Leopold, J.A.7
Loscalzo, J.8
Walsh, K.9
-
43
-
-
2642512201
-
Clades of adeno-associated viruses are widely disseminated in human tissues
-
Gao, G., Vandenberghe, L.H., Alvira, M.R., Lu, Y., Calcedo, R., Zhou, X., and Wilson, J.M. (2004) Clades of adeno-associated viruses are widely disseminated in human tissues. J. Virol., 78: 6381-6388.
-
(2004)
J. Virol.
, vol.78
, pp. 6381-6388
-
-
Gao, G.1
Vandenberghe, L.H.2
Alvira, M.R.3
Lu, Y.4
Calcedo, R.5
Zhou, X.6
Wilson, J.M.7
-
44
-
-
18444380824
-
Altering AAV tropism with mosaic viral capsids
-
Gigout, Lm, Rebollo, Pm, Clement, Nm, Warrington, K.H. Jr, Muzyczka, N., Linden, R.M., and Weber, T. (2005) Altering AAV tropism with mosaic viral capsids. Mol. Ther., 11: 856-865.
-
(2005)
Mol. Ther.
, vol.11
, pp. 856-865
-
-
Gigout, Lm.1
Rebollo, Pm.2
Clement, Nm.3
Warrington Jr., K.H.4
Muzyczka, N.5
Linden, R.M.6
Weber, T.7
-
45
-
-
0029877965
-
Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart
-
Giordano, F.J., Ping, P., McKirnan, M.D., Nozaki, S., DeMaria, A.N., Dillmann, W.H., Mathieu-Costello, O., and Hammond, H.K. (1996) Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nat. Med., 2: 534-539.
-
(1996)
Nat. Med.
, vol.2
, pp. 534-539
-
-
Giordano, F.J.1
Ping, P.2
McKirnan, M.D.3
Nozaki, S.4
DeMaria, A.N.5
Dillmann, W.H.6
Mathieu-Costello, O.7
Hammond, H.K.8
-
46
-
-
0032870158
-
Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2
-
Girod, A., Ried, M., Wobus, C., Lahm, H., Leike, K., Kleinschmidt, J., Deleage, G., and Hallek, M. (1999) Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2. Nat. Med., 5, 1052-1056.
-
(1999)
Nat. Med.
, vol.5
, pp. 1052-1056
-
-
Girod, A.1
Ried, M.2
Wobus, C.3
Lahm, H.4
Leike, K.5
Kleinschmidt, J.6
Deleage, G.7
Hallek, M.8
-
47
-
-
1542369977
-
From virus evolution to vector revolution: Use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy
-
Grimm, D., and Kay, M.A. (2003) From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy. Curr. Gene Ther., 3: 281-304.
-
(2003)
Curr. Gene Ther.
, vol.3
, pp. 281-304
-
-
Grimm, D.1
Kay, M.A.2
-
48
-
-
0033544010
-
Progress in adeno-associated virus type 2 vector production: Promises and prospects for clinical use
-
Grimm, D., and Kleinschmidt, J.A. (1999) Progress in adeno-associated virus type 2 vector production: promises and prospects for clinical use. Hum. Gene Ther., 10: 2445-2450.
-
(1999)
Hum. Gene Ther.
, vol.10
, pp. 2445-2450
-
-
Grimm, D.1
Kleinschmidt, J.A.2
-
49
-
-
0032170672
-
Heart-specific targeting of betagalactosidase by the ventricle-specific cardiac myosin light chain 2 promoter using adenovirus vectors
-
Griscelli, F., Gilardi-Hebenstreit, P., Hanania, N., Franz, W.M., Opolon, P., Perricaudet, M., and Ragot, T. (1998) Heart-specific targeting of betagalactosidase by the ventricle-specific cardiac myosin light chain 2 promoter using adenovirus vectors. Hum. Gene Ther., 9: 1919-1928.
-
(1998)
Hum. Gene Ther.
, vol.9
, pp. 1919-1928
-
-
Griscelli, F.1
Gilardi-Hebenstreit, P.2
Hanania, N.3
Franz, W.M.4
Opolon, P.5
Perricaudet, M.6
Ragot, T.7
-
50
-
-
12344255581
-
Gene transfer into rabbit arteries with adeno-associated virus and adenovirus vectors
-
Gruchala, M., Bhardwaj, S., Pajusola, K., Roy, H., Rissanen, T.T., Kokina, I., Kholova, I., Markkanen, J.E., Rutanen, J., Heikura, T., Alitalo, K., Bueler, H., and Yla-Herttuala, S. (2004a) Gene transfer into rabbit arteries with adeno-associated virus and adenovirus vectors. J. Gene Med., 6: 545-554.
-
(2004)
J. Gene Med.
, vol.6
, pp. 545-554
-
-
Gruchala, M.1
Bhardwaj, S.2
Pajusola, K.3
Roy, H.4
Rissanen, T.T.5
Kokina, I.6
Kholova, I.7
Markkanen, J.E.8
Rutanen, J.9
Heikura, T.10
Alitalo, K.11
Bueler, H.12
Yla-Herttuala, S.13
-
51
-
-
0742324064
-
Gene therapy for cardiovascular diseases
-
Gruchala, M., Roy, H., Bhardwaj, S., and Yla-Herttuala, S. (2004b) Gene therapy for cardiovascular diseases. Curr. Pharm. Des., 10: 407-423.
-
(2004)
Curr. Pharm. Des.
, vol.10
, pp. 407-423
-
-
Gruchala, M.1
Roy, H.2
Bhardwaj, S.3
Yla-Herttuala, S.4
-
52
-
-
0034992340
-
Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors
-
Halbert, C. L., Allen, J. M., and Miller, A. D. (2001) Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors. J. Virol., 75: 6615-6624.
-
(2001)
J. Virol.
, vol.75
, pp. 6615-6624
-
-
Halbert, C.L.1
Allen, J.M.2
Miller, A.D.3
-
53
-
-
1342324081
-
Angiogenic effects of dual gene transfer of bFGF and PDGF-BB after myocardial infarction
-
Hao, X., Mansson-Broberg, A., Gustafsson, T., Grinnemo, K.H., Blomberg, P., Siddiqui, A.J., Wardell, E., and Sylven, C. (2004). Angiogenic effects of dual gene transfer of bFGF and PDGF-BB after myocardial infarction. Biochem. Biophys. Res. Commun., 315: 1058-1063.
-
(2004)
Biochem. Biophys. Res. Commun.
, vol.315
, pp. 1058-1063
-
-
Hao, X.1
Mansson-Broberg, A.2
Gustafsson, T.3
Grinnemo, K.H.4
Blomberg, P.5
Siddiqui, A.J.6
Wardell, E.7
Sylven, C.8
-
54
-
-
0037368410
-
Generation and characterization of chimeric recombinant AAV vectors
-
Hauck, B., Chen, L., and Xiao, W. (2003) Generation and characterization of chimeric recombinant AAV vectors. Mol. Ther., 7: 419-425.
-
(2003)
Mol. Ther.
, vol.7
, pp. 419-425
-
-
Hauck, B.1
Chen, L.2
Xiao, W.3
-
55
-
-
8344256425
-
Human endothelial progenitor cells tolerate oxidative stress due to intrinsically high expression of manganese superoxide dismutase
-
He, T., Peterson, T.E., Holmuhamedov, E.L., Terzic, A., Caplice, N.M., Oberley, L.W., and Katusic, Z.S. (2004) Human endothelial progenitor cells tolerate oxidative stress due to intrinsically high expression of manganese superoxide dismutase. Arterioscler. Thromb. Vasc. Biol., 24: 2021-2027.
-
(2004)
Arterioscler. Thromb. Vasc. Biol.
, vol.24
, pp. 2021-2027
-
-
He, T.1
Peterson, T.E.2
Holmuhamedov, E.L.3
Terzic, A.4
Caplice, N.M.5
Oberley, L.W.6
Katusic, Z.S.7
-
56
-
-
0033982580
-
Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: Evidence for a dose-dependent effect
-
Hendel, R.C., Henry, T.D., Rocha-Singh, K., Isner, J.M., Kereiakes, D.J., Giordano, F.J., Simons, M., and Bonow, R.O. (2000) Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: evidence for a dose-dependent effect. Circulation, 101: 118-121.
-
(2000)
Circulation
, vol.101
, pp. 118-121
-
-
Hendel, R.C.1
Henry, T.D.2
Rocha-Singh, K.3
Isner, J.M.4
Kereiakes, D.J.5
Giordano, F.J.6
Simons, M.7
Bonow, R.O.8
-
57
-
-
0037453099
-
VIVA Investigators. The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis
-
Henry, T.D., Annex, B.H., McKendall, G.R., Azrin, M.A., Lopez, J.J., Giordano, F.J., Shah, P.K., Willerson, J.T., Benza, R.L., Berman, D.S., Gibson, C.M., Bajamonde, A., Rundle, A.C., Fine, J., and McCluskey, E.R. (2003) VIVA Investigators. The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis. Circulation, 107: 1359-1365.
-
(2003)
Circulation
, vol.107
, pp. 1359-1365
-
-
Henry, T.D.1
Annex, B.H.2
McKendall, G.R.3
Azrin, M.A.4
Lopez, J.J.5
Giordano, F.J.6
Shah, P.K.7
Willerson, J.T.8
Benza, R.L.9
Berman, D.S.10
Gibson, C.M.11
Bajamonde, A.12
Rundle, A.C.13
Fine, J.14
McCluskey, E.R.15
-
58
-
-
0034968125
-
Hybrid vectors based on adeno-associated vinis serotypes 2 and 5 for muscle-directed gene transfer
-
Hildinger, M., Auricchio, A., Gao, G., Wang, L., Chirmule, N., and Wilson, J.M. (2001) Hybrid vectors based on adeno-associated vinis serotypes 2 and 5 for muscle-directed gene transfer. J. Virol., 75: 6199-6203.
-
(2001)
J. Virol.
, vol.75
, pp. 6199-6203
-
-
Hildinger, M.1
Auricchio, A.2
Gao, G.3
Wang, L.4
Chirmule, N.5
Wilson, J.M.6
-
59
-
-
33745143956
-
Robust systemic transduction with AAV9 vectors in mice: Efficient global cardiac gene transfer superior to that of AAV8
-
Inagaki, K., Fuess, S., Storm, T.A., Gibson, G.A., Mctiernan, C.F., Kay, M.A., and Nakai, H. (2006) Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8. Mol. Ther., 14: 45-53.
-
(2006)
Mol. Ther.
, vol.14
, pp. 45-53
-
-
Inagaki, K.1
Fuess, S.2
Storm, T.A.3
Gibson, G.A.4
Mctiernan, C.F.5
Kay, M.A.6
Nakai, H.7
-
60
-
-
0035980172
-
Assessment of risks associated with cardiovascular gene therapy in human subjects
-
Isner, J.M., Vale, P.R., Symes, J.F., and Losordo, D.W. (2001) Assessment of risks associated with cardiovascular gene therapy in human subjects. Circ. Res., 89: 389-400.
-
(2001)
Circ. Res.
, vol.89
, pp. 389-400
-
-
Isner, J.M.1
Vale, P.R.2
Symes, J.F.3
Losordo, D.W.4
-
61
-
-
0037065852
-
Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration
-
Iwaguro, H., Yamaguchi, J., Kalka, C., Murasawa, S., Masuda, H., Hayashi, S., Silver, M., Li, T., Isner, J.M., and Asahara, T. (2002) Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation, 105: 732-738.
-
(2002)
Circulation
, vol.105
, pp. 732-738
-
-
Iwaguro, H.1
Yamaguchi, J.2
Kalka, C.3
Murasawa, S.4
Masuda, H.5
Hayashi, S.6
Silver, M.7
Li, T.8
Isner, J.M.9
Asahara, T.10
-
62
-
-
0035103833
-
Effects of in. vivo gene transfer of fibroblast growth factor-2 on cardiac function and collateral vessel formation in the microembolized rabbit heart
-
Iwatate, M., Miura, T., Ikeda, Y., Kawamura, S., Dairaku, Y., Okamura, T., Kimura, M., Yamaguchi, K., Ueno, H., and Matsuzaki, M. (2001) Effects of in. vivo gene transfer of fibroblast growth factor-2 on cardiac function and collateral vessel formation in the microembolized rabbit heart. Jpn. Circ. J, 65: 226-231.
-
(2001)
Jpn. Circ. J
, vol.65
, pp. 226-231
-
-
Iwatate, M.1
Miura, T.2
Ikeda, Y.3
Kawamura, S.4
Dairaku, Y.5
Okamura, T.6
Kimura, M.7
Yamaguchi, K.8
Ueno, H.9
Matsuzaki, M.10
-
63
-
-
24944534593
-
VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B-PDGFRbeta signaling
-
Kano, M.R., Morishita, Y., Iwata, C., Iwasaka, S., Watabe, T., Ouchi, Y., Miyazono, K., and Miyazawa, K. (2005) VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B-PDGFRbeta signaling. J. Cell Sci., 118: 3759-3768.
-
(2005)
J. Cell Sci.
, vol.118
, pp. 3759-3768
-
-
Kano, M.R.1
Morishita, Y.2
Iwata, C.3
Iwasaka, S.4
Watabe, T.5
Ouchi, Y.6
Miyazono, K.7
Miyazawa, K.8
-
64
-
-
20144386684
-
Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: The Euroinject One trial
-
Euroinject One Group
-
Kastrup, J., Jorgensen, E., Ruck, A., Tagil, K., Glogar, D., Ruzyllo, W., Botker, H.E., Dudek, D., Drvota, V., Hesse, B., Thuesen, L., Blomberg, P., Gyongyosi, M., and Sylven, C.; Euroinject One Group. (2005) Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial. J. Am. Coll. Cardiol., 45: 982-988.
-
(2005)
J. Am. Coll. Cardiol.
, vol.45
, pp. 982-988
-
-
Kastrup, J.1
Jorgensen, E.2
Ruck, A.3
Tagil, K.4
Glogar, D.5
Ruzyllo, W.6
Botker, H.E.7
Dudek, D.8
Drvota, V.9
Hesse, B.10
Thuesen, L.11
Blomberg, P.12
Gyongyosi, M.13
Sylven, C.14
-
65
-
-
19444363187
-
Widespread and early myocardial gene expression by adeno-associated virus vector type 6 with a beta-actin hybrid promoter
-
Kawamoto, S., Shi, Q., Nitta, Y., Miyazaki, J., and Allen, M.D. (2005) Widespread and early myocardial gene expression by adeno-associated virus vector type 6 with a beta-actin hybrid promoter. Mol. Ther., 11: 980-985.
-
(2005)
Mol. Ther.
, vol.11
, pp. 980-985
-
-
Kawamoto, S.1
Shi, Q.2
Nitta, Y.3
Miyazaki, J.4
Allen, M.D.5
-
66
-
-
0041806502
-
Looking into the safety of AAV vectors
-
Kay, M.A., and Nakai, H. (2003) Looking into the safety of AAV vectors. Nature, 424: 251.
-
(2003)
Nature
, vol.424
, pp. 251
-
-
Kay, M.A.1
Nakai, H.2
-
67
-
-
0036829025
-
Regulation of angiogenesis by glycogen synthase kinase-3beta
-
Kim, H.S., Skurk, C., Thomas, S.R., Bialik, A., Suhara, T., Kureishi, Y., Birnbaum, M., Keaney, J.F. Jr, and Walsh, K. (2002) Regulation of angiogenesis by glycogen synthase kinase-3beta. J. Biol. Chem., 277: 41888-41896.
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 41888-41896
-
-
Kim, H.S.1
Skurk, C.2
Thomas, S.R.3
Bialik, A.4
Suhara, T.5
Kureishi, Y.6
Birnbaum, M.7
Keaney Jr., J.F.8
Walsh, K.9
-
68
-
-
11844288284
-
Potential oncogene activity of the woodchuck hepatitis post-transcriptional regulatory element (WPRE)
-
Kingsman, S.M., Mitrophanous, K., and Olsen, J.C. (2005) Potential oncogene activity of the woodchuck hepatitis post-transcriptional regulatory element (WPRE). Gene Ther., 12: 3-4.
-
(2005)
Gene Ther.
, vol.12
, pp. 3-4
-
-
Kingsman, S.M.1
Mitrophanous, K.2
Olsen, J.C.3
-
69
-
-
33745965951
-
Combination of in. vivo angiopoietin-1 gene transfer and autologous bone marrow cell implantation for functional therapeutic angiogenesis
-
Kobayashi, K., Kondo, T., Inoue, N., Aoki, M., Mizuno, M., Komori, K., Yoshida, J., and Murohara, T. (2006) Combination of in. vivo angiopoietin-1 gene transfer and autologous bone marrow cell implantation for functional therapeutic angiogenesis. Arterioscler. Thromb. Vasc. Biol., 26: 1465-1472.
-
(2006)
Arterioscler. Thromb. Vasc. Biol.
, vol.26
, pp. 1465-1472
-
-
Kobayashi, K.1
Kondo, T.2
Inoue, N.3
Aoki, M.4
Mizuno, M.5
Komori, K.6
Yoshida, J.7
Murohara, T.8
-
70
-
-
16544390737
-
Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells
-
Kong, D., Melo, L.G., Mangi, A.A., Zhang, L., Lopez-Ilasaca, M., Perrella, M.A., Liew, C.C., Pratt, R.E., and Dzau, V.J. (2004) Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation, 109: 1769-1775.
-
(2004)
Circulation
, vol.109
, pp. 1769-1775
-
-
Kong, D.1
Melo, L.G.2
Mangi, A.A.3
Zhang, L.4
Lopez-Ilasaca, M.5
Perrella, M.A.6
Liew, C.C.7
Pratt, R.E.8
Dzau, V.J.9
-
71
-
-
0025214094
-
Site-specific integration by adeno-associated virus
-
Kotin, R.M., Siniscalco, M., Samulski, R.J., Zhu, X.D., Hunter, L., Laughlin, C.A., McLaughlin, S., Muzyczka, N., Rocchi, M., and Berns, K.I. (1990) Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. USA, 87: 2211-2215.
-
(1990)
Proc. Natl. Acad. Sci. USA
, vol.87
, pp. 2211-2215
-
-
Kotin, R.M.1
Siniscalco, M.2
Samulski, R.J.3
Zhu, X.D.4
Hunter, L.5
Laughlin, C.A.6
McLaughlin, S.7
Muzyczka, N.8
Rocchi, M.9
Berns, K.I.10
-
72
-
-
33745643590
-
Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: A double-blind randomized trial
-
Kusumanto, Y.H., Van Weel, V., Mulder, N.H., Smit, A.J., Van den Dungen J.J.A.M., Hooymans, J.M.M., Sluiter, W.J., Tio, R.A., Quax, P.H.A., Gans, R.O.B., Dullaart, R.P.F., and Hospers, G.A.P. (2006) Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial. Hum. Gene Ther., 17: 683-691.
-
(2006)
Hum. Gene Ther.
, vol.17
, pp. 683-691
-
-
Kusumanto, Y.H.1
Van Weel, V.2
Mulder, N.H.3
Smit, A.J.4
Van den Dungen, J.J.A.M.5
Hooymans, J.M.M.6
Sluiter, W.J.7
Tio, R.A.8
Quax, P.H.A.9
Gans, R.O.B.10
Dullaart, R.P.F.11
Hospers, G.A.P.12
-
73
-
-
0033667440
-
Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: Results of a phase I open-label dose escalation study
-
Laham, R.J., Chronos, N.A., Pike, M., Leimbach, M.E., Udelson, J.E., Pearlman, J.D., Pettigrew, R.I., Whitehouse, M.J., Yoshizawa, C., and Simons, M. (2000) Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study. J. Am. Coll. Cardiol., 36: 2132-2139.
-
(2000)
J. Am. Coll. Cardiol.
, vol.36
, pp. 2132-2139
-
-
Laham, R.J.1
Chronos, N.A.2
Pike, M.3
Leimbach, M.E.4
Udelson, J.E.5
Pearlman, J.D.6
Pettigrew, R.I.7
Whitehouse, M.J.8
Yoshizawa, C.9
Simons, M.10
-
74
-
-
0031580712
-
Gene transfer into the carotid artery using an adventitial collar: Comparison of the effectiveness of the plasmid-liposome complexes, retroviruses, pseudotyped retroviruses, and adenoviruses
-
Laitinen, M., Pakkanen, T., Donetti, E., Baetta, R., Luoma, J., Lehtolainen, P., Viita, H., Agrawal, R., Miyanohara, A., Friedmann, T., Risau, W., Martin, J.F., Soma, M., and Yla-Herttuala, S. (1997) Gene transfer into the carotid artery using an adventitial collar: comparison of the effectiveness of the plasmid-liposome complexes, retroviruses, pseudotyped retroviruses, and adenoviruses. Hum. Gene Ther., 8: 1645-1650.
-
(1997)
Hum. Gene Ther.
, vol.8
, pp. 1645-1650
-
-
Laitinen, M.1
Pakkanen, T.2
Donetti, E.3
Baetta, R.4
Luoma, J.5
Lehtolainen, P.6
Viita, H.7
Agrawal, R.8
Miyanohara, A.9
Friedmann, T.10
Risau, W.11
Martin, J.F.12
Soma, M.13
Yla-Herttuala, S.14
-
75
-
-
0034702905
-
VEGF gene delivery to myocardium: Deleterious effects of unregulated expression
-
Lee, R.J., Springer, M.L., Blanco-Bose, W.E., Shaw, R., Ursell, P.C., and Blau, H.M. (2000) VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation, 102: 898-901.
-
(2000)
Circulation
, vol.102
, pp. 898-901
-
-
Lee, R.J.1
Springer, M.L.2
Blanco-Bose, W.E.3
Shaw, R.4
Ursell, P.C.5
Blau, H.M.6
-
76
-
-
0033970878
-
PR39, a peptide regulator of angiogenesis
-
Li, J., Post, M., Volk, R., Gao, Y., Li, M., Metais, C., Sato, K., Tsai, J., Aird, W., Rosenberg, R.D., Hampton, T.G., Sellke, F., Carmeliet, P., and Simons, M. (2000) PR39, a peptide regulator of angiogenesis. Nat. Med., 6:49-55.
-
(2000)
Nat. Med.
, vol.6
, pp. 49-55
-
-
Li, J.1
Post, M.2
Volk, R.3
Gao, Y.4
Li, M.5
Metais, C.6
Sato, K.7
Tsai, J.8
Aird, W.9
Rosenberg, R.D.10
Hampton, T.G.11
Sellke, F.12
Carmeliet, P.13
Simons, M.14
-
77
-
-
28844492583
-
Endothelial progenitor cell dysfunction in type 1 diabetes: Another consequence of oxidative stress?
-
Loomans, C.J., De Koning, E.J., Staal, F.J,. Rabelink, T.J., and Zonneveld, A.J. (2005) Endothelial progenitor cell dysfunction in type 1 diabetes: another consequence of oxidative stress?. Antioxid. Redox. Signal, 7: 1468-1475.
-
(2005)
Antioxid. Redox. Signal
, vol.7
, pp. 1468-1475
-
-
Loomans, C.J.1
De Koning, E.J.2
Staal, F.J.3
Rabelink, T.J.4
Zonneveld, A.J.5
-
78
-
-
2942572769
-
Therapeutic angiogenesis and vasculogenesis for ischemic disease: Pan II: Cell-based therapies
-
Losordo, D.W., and Dimmeler, S. (2004) Therapeutic angiogenesis and vasculogenesis for ischemic disease: pan II: cell-based therapies. Circulation, 109: 2692-2697.
-
(2004)
Circulation
, vol.109
, pp. 2692-2697
-
-
Losordo, D.W.1
Dimmeler, S.2
-
79
-
-
33745123717
-
A constitutively active hypoxia-inducible factor-1alpha/VP16 hybrid factor activates expression of the human B-type natriuretic peptide gene
-
Luo, Y., Jiang, C., Belanger, A.J., Akita, G.Y., Wadsworth, S.C., Gregory, R.J., and Vincent, K.A. (2006) A constitutively active hypoxia-inducible factor-1alpha/VP16 hybrid factor activates expression of the human B-type natriuretic peptide gene. Mol. Pharmacol., 69: 1953-1962.
-
(2006)
Mol. Pharmacol.
, vol.69
, pp. 1953-1962
-
-
Luo, Y.1
Jiang, C.2
Belanger, A.J.3
Akita, G.Y.4
Wadsworth, S.C.5
Gregory, R.J.6
Vincent, K.A.7
-
81
-
-
10944269753
-
Integration of adeno-associated virus (AAV) and recombinant AAV vectors
-
McCarty, D.M., Young, S.M. Jr, and Samulski, R.J. (2004) Integration of adeno-associated virus (AAV) and recombinant AAV vectors. Annu. Rev. Genet., 38: 819-845.
-
(2004)
Annu. Rev. Genet.
, vol.38
, pp. 819-845
-
-
McCarty, D.M.1
Young Jr., S.M.2
Samulski, R.J.3
-
82
-
-
0035667112
-
Recombinant adeno-associated virus vector-transduced vascular endothelial cells express the thrombomodulin transgene under the regulation of enhanced plasminogen activator inhibitor-1 promoter
-
Mimur, J., Muramatsu, S., Hakamada, Y., Mori, K., Kikuchi, J., Urabe, M., Madoiwa, S., Ozawa, K., and Sakata, Y. (2001) Recombinant adeno-associated virus vector-transduced vascular endothelial cells express the thrombomodulin transgene under the regulation of enhanced plasminogen activator inhibitor-1 promoter. Gene Ther., 8: 1690-1697.
-
(2001)
Gene Ther.
, vol.8
, pp. 1690-1697
-
-
Mimur, J.1
Muramatsu, S.2
Hakamada, Y.3
Mori, K.4
Kikuchi, J.5
Urabe, M.6
Madoiwa, S.7
Ozawa, K.8
Sakata, Y.9
-
83
-
-
0033978147
-
AAV vectors: Is clinical success on the horizon?
-
Monahan, P.E., and Samulski, R.J. (2000) AAV vectors: is clinical success on the horizon? Gene Ther., 7: 24-30.
-
(2000)
Gene Ther.
, vol.7
, pp. 24-30
-
-
Monahan, P.E.1
Samulski, R.J.2
-
84
-
-
0030972807
-
Transcriptional regulation by cyclic AMP
-
Montminy, M. (1997) Transcriptional regulation by cyclic AMP. Annu. Rev. BioChem., 66:807-822.
-
(1997)
Annu. Rev. BioChem.
, vol.66
, pp. 807-822
-
-
Montminy, M.1
-
85
-
-
3042511472
-
Therapeutic angiogenesis using hepatocyte growth factor (HGF)
-
Morishita, R., Aoki, M., Hashiya, N., Yamasaki, K., Kurinami, H., Shimizu, S., Makino, H., Takesya, Y., Azuma, J., and Ogihara, T. (2004) Therapeutic angiogenesis using hepatocyte growth factor (HGF). Curr. Gene Ther., 4: 199-206.
-
(2004)
Curr. Gene Ther.
, vol.4
, pp. 199-206
-
-
Morishita, R.1
Aoki, M.2
Hashiya, N.3
Yamasaki, K.4
Kurinami, H.5
Shimizu, S.6
Makino, H.7
Takesya, Y.8
Azuma, J.9
Ogihara, T.10
-
86
-
-
3042841635
-
Anti-HIV-1 gene expressing lentiviral vectors as an adjunctive therapy for HIV-1 infection
-
Morris, K.V., and Rossi, J.J. (2004) Anti-HIV-1 gene expressing lentiviral vectors as an adjunctive therapy for HIV-1 infection. Curr. HIV. Res., 2: 185-191.
-
(2004)
Curr. HIV. Res.
, vol.2
, pp. 185-191
-
-
Morris, K.V.1
Rossi, J.J.2
-
87
-
-
0036726577
-
Tropism-modified adenoviral and adeno-associated viral vectors for gene therapy
-
Nicklin, S.A., and Baker, A.H. (2002) Tropism-modified adenoviral and adeno-associated viral vectors for gene therapy. Curr. Gene Ther., 2: 273-93.
-
(2002)
Curr. Gene Ther.
, vol.2
, pp. 273-293
-
-
Nicklin, S.A.1
Baker, A.H.2
-
88
-
-
0034843445
-
Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells
-
Nicklin, S.A., Buening, H., Dishart, K.L., de Alwis, M., Girod, A., Hacker, U., Thrasher, A.J., Ali, R.R., Hallek, M., and Baker, A.H. (2001a) Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells. Mol. Ther., 4: 174-181.
-
(2001)
Mol. Ther.
, vol.4
, pp. 174-181
-
-
Nicklin, S.A.1
Buening, H.2
Dishart, K.L.3
de Alwis, M.4
Girod, A.5
Hacker, U.6
Thrasher, A.J.7
Ali, R.R.8
Hallek, M.9
Baker, A.H.10
-
89
-
-
0035570193
-
Analysis of cell-specific promoters for viral gene therapy targeted at the vascular endothelium
-
Nicklin, S.A., Reynolds, P.N., Brosnan, M.J., White, S.J., Curiel, D.T., Dominiczak, A.F., and Baker, A.H. (2001b) Analysis of cell-specific promoters for viral gene therapy targeted at the vascular endothelium. Hypertension, 38: 65-70.
-
(2001)
Hypertension
, vol.38
, pp. 65-70
-
-
Nicklin, S.A.1
Reynolds, P.N.2
Brosnan, M.J.3
White, S.J.4
Curiel, D.T.5
Dominiczak, A.F.6
Baker, A.H.7
-
90
-
-
33747518710
-
Recombinant Adeno-Associated Virus Serotype 9 Leads to Preferential Cardiac Transduction In Vivo
-
Pacak, C.A., Mah, C.S., Thattaliyath, B.D., Conlon, T.J., Lewis, M.A., Cloutier, D.E., Zolotukhin, I., Tarantal, A.F., and Byrne, B.J. (2006) Recombinant Adeno-Associated Virus Serotype 9 Leads to Preferential Cardiac Transduction In Vivo. Circ. Res., 99: e3-9.
-
(2006)
Circ. Res.
, vol.99
-
-
Pacak, C.A.1
Mah, C.S.2
Thattaliyath, B.D.3
Conlon, T.J.4
Lewis, M.A.5
Cloutier, D.E.6
Zolotukhin, I.7
Tarantal, A.F.8
Byrne, B.J.9
-
91
-
-
4344573909
-
Hypoxia-regulated therapeutic gene as a preemptive treatment strategy against ischemia/reperfusion tissue injury
-
Pachori, A.S., Melo, L.G., Hart, M.L., Noiseux, N., Zhang, L., Morello, F., Solomon, S.D., Stahl, G.L., Pratt, R.E., and Dzau, V.J. (2004) Hypoxia-regulated therapeutic gene as a preemptive treatment strategy against ischemia/reperfusion tissue injury. Proc. Natl. Acad. Sci. USA, 101: 12282-12287.
-
(2004)
Proc. Natl. Acad. Sci. USA
, vol.101
, pp. 12282-12287
-
-
Pachori, A.S.1
Melo, L.G.2
Hart, M.L.3
Noiseux, N.4
Zhang, L.5
Morello, F.6
Solomon, S.D.7
Stahl, G.L.8
Pratt, R.E.9
Dzau, V.J.10
-
92
-
-
31644436481
-
Chronic recurrent myocardial ischemic injury is significantly attenuated by pre-emptive adeno-associated virus heme oxygenase-1 gene delivery
-
Pachori, A.S., Melo, L.G., Zhang, L., Solomon, S.D., and Dzau, V.J. (2006) Chronic recurrent myocardial ischemic injury is significantly attenuated by pre-emptive adeno-associated virus heme oxygenase-1 gene delivery. J. Am. Coll. Cardiol., 47: 635-643.
-
(2006)
J. Am. Coll. Cardiol.
, vol.47
, pp. 635-643
-
-
Pachori, A.S.1
Melo, L.G.2
Zhang, L.3
Solomon, S.D.4
Dzau, V.J.5
-
93
-
-
0036828063
-
Cell-type-specific characteristics modulate the transduction efficiency of adeno-associated virus type 2 and restrain infection of endothelial cells
-
Pajusola, K., Gruchala, M., Joch, H., Luscher, T.F., Yla-Herttuala, S., and Bueler, H. (2002) Cell-type-specific characteristics modulate the transduction efficiency of adeno-associated virus type 2 and restrain infection of endothelial cells. J. Virol., 76: 11530-11540.
-
(2002)
J. Virol.
, vol.76
, pp. 11530-11540
-
-
Pajusola, K.1
Gruchala, M.2
Joch, H.3
Luscher, T.F.4
Yla-Herttuala, S.5
Bueler, H.6
-
94
-
-
23444450886
-
Stabilized HIF-1alpha is superior to VEGF for angiogenesis in skeletal muscle via adeno-associated virus gene transfer
-
Pajusola, K., Kunnapuu, J., Vuorikoski, S., Soronen, J., Andre, H., Pereira, T., Korpisalo, P., Yla-Herttuala, S., Poellinger, L., and Alitalo, K. (2005) Stabilized HIF-1alpha is superior to VEGF for angiogenesis in skeletal muscle via adeno-associated virus gene transfer. FASEB J., 19: 1365-1367.
-
(2005)
FASEB J.
, vol.19
, pp. 1365-1367
-
-
Pajusola, K.1
Kunnapuu, J.2
Vuorikoski, S.3
Soronen, J.4
Andre, H.5
Pereira, T.6
Korpisalo, P.7
Yla-Herttuala, S.8
Poellinger, L.9
Alitalo, K.10
-
95
-
-
12144276611
-
Ischaemic preconditioning protects against ischaemia/reperfusion injury: Emerging concepts
-
Pasupathy, S., and Homer-Vanniasinkam, S. (2005) Ischaemic preconditioning protects against ischaemia/reperfusion injury: emerging concepts. Eur. J. Vasc. Endovasc. Surg., 29: 106-15.
-
(2005)
Eur. J. Vasc. Endovasc. Surg.
, vol.29
, pp. 106-115
-
-
Pasupathy, S.1
Homer-Vanniasinkam, S.2
-
96
-
-
16644398023
-
Cancer cells as targets for lentivirus-mediated gene transfer and gene therapy
-
Pellinen, R., Hakkarainen, T., Wahlfors, T., Tulikami, K., Ketola, A., Tenhunen, A., Salonen, T., and Wahlfors, J. (2004) Cancer cells as targets for lentivirus-mediated gene transfer and gene therapy. Int. J. Oncol., 25: 1753-1762.
-
(2004)
Int. J. Oncol.
, vol.25
, pp. 1753-1762
-
-
Pellinen, R.1
Hakkarainen, T.2
Wahlfors, T.3
Tulikami, K.4
Ketola, A.5
Tenhunen, A.6
Salonen, T.7
Wahlfors, J.8
-
97
-
-
0037199399
-
Defining gene transfer before expecting gene therapy: Putting the horse before the cart
-
Pislaru, S., Janssens, S.P., Gersh, B.J., and Simari, R.D. (2002) Defining gene transfer before expecting gene therapy: putting the horse before the cart. Circulation, 106: 631-636.
-
(2002)
Circulation
, vol.106
, pp. 631-636
-
-
Pislaru, S.1
Janssens, S.P.2
Gersh, B.J.3
Simari, R.D.4
-
98
-
-
20444452567
-
Gene transfer for ischemic cardiovascular disease: Is this the end of the beginning or the beginning of the end?
-
Pislaru, S.V. and Simari, S.D. (2005) Gene transfer for ischemic cardiovascular disease: is this the end of the beginning or the beginning of the end? Nat. Clin. Pract. Cardiovasc. Med, 2:138-144
-
(2005)
Nat. Clin. Pract. Cardiovasc. Med
, vol.2
, pp. 138-144
-
-
Pislaru, S.V.1
Simari, S.D.2
-
99
-
-
33645409031
-
Adenoviral PR39 improves blood flow and myocardial function in a pig model of chronic myocardial ischemia by enhancing collateral formation
-
Post, M.J., Sato, K., Murakami, M., Bao, J., Tirziu, D., Pearlman, J.D., and Simons, M. (2006) Adenoviral PR39 improves blood flow and myocardial function in a pig model of chronic myocardial ischemia by enhancing collateral formation. Am. J. Physiol. Regul. Integr. Comp. Physiol., 290: R494-500.
-
(2006)
Am. J. Physiol. Regul. Integr. Comp. Physiol.
, vol.290
-
-
Post, M.J.1
Sato, K.2
Murakami, M.3
Bao, J.4
Tirziu, D.5
Pearlman, J.D.6
Simons, M.7
-
100
-
-
12344253201
-
Therapeutic angiogenesis for critical limb ischemia: Design of the hepatocyte growth factor therapeutic angiogenesis clinical trial
-
Powell, R.J., Dormandy, J., Simons, M., Morishita, R., and Annex, B.H. (2004) Therapeutic angiogenesis for critical limb ischemia: design of the hepatocyte growth factor therapeutic angiogenesis clinical trial. Vasc. Med., 9: 193-198.
-
(2004)
Vasc. Med.
, vol.9
, pp. 193-198
-
-
Powell, R.J.1
Dormandy, J.2
Simons, M.3
Morishita, R.4
Annex, B.H.5
-
101
-
-
4444352441
-
Cross-dressing the virion: The transcapsidation of adeno-associated virus serotypes functionally defines subgroups
-
Rabinowitz, J.E., Bowles, D.E., Faust, S.M., Ledford, J.G., Cunningham, S.E., and Samulski, R.J. (2004) Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups. J. Virol., 78: 4421-4432.
-
(2004)
J. Virol.
, vol.78
, pp. 4421-4432
-
-
Rabinowitz, J.E.1
Bowles, D.E.2
Faust, S.M.3
Ledford, J.G.4
Cunningham, S.E.5
Samulski, R.J.6
-
102
-
-
12244262784
-
12th Annual congress of the European society of gene therapy
-
Read, M.L., Spice, R., Parker, A.L., Mir, S., and Logan, A. (2005) 12th Annual congress of the European society of gene therapy. Expert. Opin. Biol. Ther., 5: 137-141.
-
(2005)
Expert. Opin. Biol. Ther.
, vol.5
, pp. 137-141
-
-
Read, M.L.1
Spice, R.2
Parker, A.L.3
Mir, S.4
Logan, A.5
-
103
-
-
4644285407
-
Sitespecific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors
-
Recchia, A., Perani, L., Sartori, D., Olgiati, C., and Mavilio, F. (2004) Sitespecific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors. Mol. Ther., 10: 660-670.
-
(2004)
Mol. Ther.
, vol.10
, pp. 660-670
-
-
Recchia, A.1
Perani, L.2
Sartori, D.3
Olgiati, C.4
Mavilio, F.5
-
104
-
-
0034719980
-
Adeno-associated virus vector transduction of vascular smooth muscle cells in vivo
-
Richter, M., Iwata, A., Nyhuis, J., Nitta, Y., Miller, A.D., Halbert, C.L., and Allen, M.D. (2000) Adeno-associated virus vector transduction of vascular smooth muscle cells in vivo. Physiol. Genomics, 2: 117-127.
-
(2000)
Physiol. Genomics
, vol.2
, pp. 117-127
-
-
Richter, M.1
Iwata, A.2
Nyhuis, J.3
Nitta, Y.4
Miller, A.D.5
Halbert, C.L.6
Allen, M.D.7
-
105
-
-
0037714018
-
VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses
-
Rissanen, T.T., Markkanen, J.E., Gruchala, M., Heikura, T., Puranen, A., Kettunen, M.I., Kholova, I., Kauppinen, R.A., Achen, M.G., Stacker, S.A., Alitalo, K., and Yla-Herttuala, S. (2003a) VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ. Res., 92: 1098-1106.
-
(2003)
Circ. Res.
, vol.92
, pp. 1098-1106
-
-
Rissanen, T.T.1
Markkanen, J.E.2
Gruchala, M.3
Heikura, T.4
Puranen, A.5
Kettunen, M.I.6
Kholova, I.7
Kauppinen, R.A.8
Achen, M.G.9
Stacker, S.A.10
Alitalo, K.11
Yla-Herttuala, S.12
-
106
-
-
0037265253
-
Fibroblast growth factor 4 induces vascular permeability, angiogenesis and arteriogenesis in a rabbit hindlimb ischemia model
-
Rissanen, T.T., Markkanen, J.E., Arve, K., Rutanen, J., Kettimen, M.I., Vajanto, I., Jauhiainen, S., Cashion, L., Gruchala, M., Narvanen, O., Taipale, P., Kauppinen, R.A., Rubanyi, G.M., and Yla-Herttuala, S. (2003b) Fibroblast growth factor 4 induces vascular permeability, angiogenesis and arteriogenesis in a rabbit hindlimb ischemia model. FASEB J., 17: 100-2.
-
(2003)
FASEB J.
, vol.17
, pp. 100-102
-
-
Rissanen, T.T.1
Markkanen, J.E.2
Arve, K.3
Rutanen, J.4
Kettimen, M.I.5
Vajanto, I.6
Jauhiainen, S.7
Cashion, L.8
Gruchala, M.9
Narvanen, O.10
Taipale, P.11
Kauppinen, R.A.12
Rubanyi, G.M.13
Yla-Herttuala, S.14
-
107
-
-
33747584384
-
Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice
-
Riviere, C., Danos, O., and Douar, A.M. (2006) Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice. Gene Ther., 13: 1300-1308.
-
(2006)
Gene Ther.
, vol.13
, pp. 1300-1308
-
-
Riviere, C.1
Danos, O.2
Douar, A.M.3
-
108
-
-
0031984786
-
Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes Rother than AAV type 2
-
Rutledge E, Halbert C, and Russell D. Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes Rother than AAV type 2. J. Virol., 1998; 72(1): 309-319.
-
(1998)
J. Virol.
, vol.72
, Issue.1
, pp. 309-319
-
-
Rutledge, E.1
Halbert, C.2
Russell, D.3
-
109
-
-
0037829897
-
Lentivirus vector-mediated gene transfer to cardiomyocytes
-
Sakoda, T., Kasahara, N., and Kedes, L. (2003) Lentivirus vector-mediated gene transfer to cardiomyocytes. Methods. Mol. Biol., 219: 53-70.
-
(2003)
Methods. Mol. Biol.
, vol.219
, pp. 53-70
-
-
Sakoda, T.1
Kasahara, N.2
Kedes, L.3
-
110
-
-
33749074728
-
Beta-adrenoceptor blockade markedly attenuates transgene expression from cytomegalovirus promoters within the cardiovascular system
-
Salem, H.K., Ranjzad, P., Driessen, A., Appleby, C.E., Heagerty, A.M., and Kingston, P.A. (2006) Beta-adrenoceptor blockade markedly attenuates transgene expression from cytomegalovirus promoters within the cardiovascular system. Arterioscler. Thromb. Vasc. Biol., 26: 2267-2274.
-
(2006)
Arterioscler. Thromb. Vasc. Biol.
, vol.26
, pp. 2267-2274
-
-
Salem, H.K.1
Ranjzad, P.2
Driessen, A.3
Appleby, C.E.4
Heagerty, A.M.5
Kingston, P.A.6
-
111
-
-
33644618775
-
Bone-marrow-derived progenitor cell therapy in need of proof of concept: Design of the REPAIR-AMI trial
-
Schachinger, V., Tonn, T., Dimmeler, S., and Zeiher, A.M. (2006) Bone-marrow-derived progenitor cell therapy in need of proof of concept: design of the REPAIR-AMI trial. Nat. Clin. Pract. Cardiovasc. Med., 3: S23-8.
-
(2006)
Nat. Clin. Pract. Cardiovasc. Med.
, vol.3
-
-
Schachinger, V.1
Tonn, T.2
Dimmeler, S.3
Zeiher, A.M.4
-
112
-
-
0026646222
-
Basic fibroblast growth factor modulates the mitogenic potency of the platelet-derived growth factor (PDGF) isoforms by specific upregulation of the PDGF alpha receptor in vascular smooth muscle cells
-
Schollmann, C., Grugel, R., Tatje, D., Hoppe, J., Folkman, J., Marme, D., and Weich, H.A. (1992) Basic fibroblast growth factor modulates the mitogenic potency of the platelet-derived growth factor (PDGF) isoforms by specific upregulation of the PDGF alpha receptor in vascular smooth muscle cells. J. Biol. Chem., 267: 18032-18039.
-
(1992)
J. Biol. Chem.
, vol.267
, pp. 18032-18039
-
-
Schollmann, C.1
Grugel, R.2
Tatje, D.3
Hoppe, J.4
Folkman, J.5
Marme, D.6
Weich, H.A.7
-
113
-
-
0035023584
-
Reversal of experimental diabetic neuropathy by VEGF gene transfer
-
Schratzberger, P., Walter, D.H., Rittig, K., Bahlmann, F.H., Pola, R., Curry, C., Silver, M., Krainin, J.G., Weinberg, D.H., Ropper, A.H., and Isner, J.M. (2001) Reversal of experimental diabetic neuropathy by VEGF gene transfer. J. Clin. Invest., 107: 1083-1092.
-
(2001)
J. Clin. Invest.
, vol.107
, pp. 1083-1092
-
-
Schratzberger, P.1
Walter, D.H.2
Rittig, K.3
Bahlmann, F.H.4
Pola, R.5
Curry, C.6
Silver, M.7
Krainin, J.G.8
Weinberg, D.H.9
Ropper, A.H.10
Isner, J.M.11
-
114
-
-
0037162715
-
HIV-1 integration in the human genome favors active genes and local hotspots
-
Schroder, A.R., Shinn, P., Chen, H., Berry, C., Ecker, J.R., and Bushman, F. (2002) HIV-1 integration in the human genome favors active genes and local hotspots. Cell, 110: 521-529.
-
(2002)
Cell
, vol.110
, pp. 521-529
-
-
Schroder, A.R.1
Shinn, P.2
Chen, H.3
Berry, C.4
Ecker, J.R.5
Bushman, F.6
-
115
-
-
0033520043
-
Interindividual heterogeneity in the hypoxic regulation of VEGF: Significance for the development of the coronary artery collateral circulation
-
Schultz, A., Lavie, L., Hochberg, I., Beyar, R., Stone, T., Skorecki, K., Lavie, P., Roguin, A., and Levy, A.P. (1999) Interindividual heterogeneity in the hypoxic regulation of VEGF: significance for the development of the coronary artery collateral circulation. Circulation, 100: 547-52.
-
(1999)
Circulation
, vol.100
, pp. 547-552
-
-
Schultz, A.1
Lavie, L.2
Hochberg, I.3
Beyar, R.4
Stone, T.5
Skorecki, K.6
Lavie, P.7
Roguin, A.8
Levy, A.P.9
-
116
-
-
30744440945
-
Adeno-associated virus types 5 and 6 use distinct receptors for cell entry
-
Seiler, M.P., Miller, A.D., Zabner, J., and Halbert, C.L. (2006) Adeno-associated virus types 5 and 6 use distinct receptors for cell entry. Hum. Gene Ther., 17: 10-19.
-
(2006)
Hum. Gene Ther.
, vol.17
, pp. 10-19
-
-
Seiler, M.P.1
Miller, A.D.2
Zabner, J.3
Halbert, C.L.4
-
117
-
-
33645456779
-
Insertional mutagenesis at positions 520 and 584 of adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors with eliminated heparin- binding ability and introduced novel tropism
-
Shi, X., Fang, G., and Shi, W. (2006) Insertional mutagenesis at positions 520 and 584 of adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors with eliminated heparin- binding ability and introduced novel tropism. Hum. Gene Ther., 17: 353-361.
-
(2006)
Hum. Gene Ther.
, vol.17
, pp. 353-361
-
-
Shi, X.1
Fang, G.2
Shi, W.3
-
118
-
-
0036196808
-
AAV-mediated VEGF gene transfer into skeletal muscle stimulates angiogenesis and improves blood flow in a rat hindlimb ischemia model
-
Shimpo, M., Kieda, U., Maeda, Y., Takahashi, M., Miyashita, H., Miaukami, H., Urale, M., Kume, A., Takizawa, T., Shibuya, M., Ozawa, K., and Shimada, K. (2002) AAV-mediated VEGF gene transfer into skeletal muscle stimulates angiogenesis and improves blood flow in a rat hindlimb ischemia model. Cardiovasc. Res., 53: 993-1001.
-
(2002)
Cardiovasc. Res.
, vol.53
, pp. 993-1001
-
-
Shimpo, M.1
Kieda, U.2
Maeda, Y.3
Takahashi, M.4
Miyashita, H.5
Miaukami, H.6
Urale, M.7
Kume, A.8
Takizawa, T.9
Shibuya, M.10
Ozawa, K.11
Shimada, K.12
-
119
-
-
33644623600
-
Synergistic effect of combined intramyocardial CD34+ cells and VEGF2 gene therapy after MI
-
Shintani, S., Kusano, K., Ii, M., Iwakura, A., Heyd, L., Curry, C., Wecker, A., Gavin, M., Ma, H., Kearney, M., Silver, M., Thorne, T., Murohara, T., and Losordo, D.W. (2006) Synergistic effect of combined intramyocardial CD34+ cells and VEGF2 gene therapy after MI. Nat. Clin. Pract. Cardiovasc. Med., 3: S123-8.
-
(2006)
Nat. Clin. Pract. Cardiovasc. Med.
, vol.3
-
-
Shintani, S.1
Kusano, K.2
Ii, M.3
Iwakura, A.4
Heyd, L.5
Curry, C.6
Wecker, A.7
Gavin, M.8
Ma, H.9
Kearney, M.10
Silver, M.11
Thorne, T.12
Murohara, T.13
Losordo, D.W.14
-
120
-
-
0036275028
-
Intramyocardial injection of naked DNA encoding HIF-1alpha/VP16 hybrid to enhance angiogenesis in an acute myocardial infarction model in the rat
-
Shyu, K.G., Wang, M.T., Wang, B.W., Chang, C.C., Leu, J.G., Kuan, P., and Chang, H. (2002) Intramyocardial injection of naked DNA encoding HIF-1alpha/VP16 hybrid to enhance angiogenesis in an acute myocardial infarction model in the rat. Cardiovasc. Res., 54: 576-583.
-
(2002)
Cardiovasc. Res.
, vol.54
, pp. 576-583
-
-
Shyu, K.G.1
Wang, M.T.2
Wang, B.W.3
Chang, C.C.4
Leu, J.G.5
Kuan, P.6
Chang, H.7
-
121
-
-
33646760315
-
Mosaic vectors comprised of modified AAV1 capsid proteins for efficient vector purification and targeting to vascular endothelial cells
-
Stachler, M.D., and Bartlett, J.S. (2006) Mosaic vectors comprised of modified AAV1 capsid proteins for efficient vector purification and targeting to vascular endothelial cells. Gene Ther., 13: 926-931.
-
(2006)
Gene Ther.
, vol.13
, pp. 926-931
-
-
Stachler, M.D.1
Bartlett, J.S.2
-
122
-
-
0033527634
-
Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers
-
Stacker, S.A., Stenvers, K., Caesar, C., Vitali, A., Domagala, T., Nice, E., Roufail, S., Simpson, R.J., Moritz, R., Karpanen, T., Alitalo, K., and Achen, M.G. (1999) Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers. J. Biol. Chem., 274: 32127-32136.
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 32127-32136
-
-
Stacker, S.A.1
Stenvers, K.2
Caesar, C.3
Vitali, A.4
Domagala, T.5
Nice, E.6
Roufail, S.7
Simpson, R.J.8
Moritz, R.9
Karpanen, T.10
Alitalo, K.11
Achen, M.G.12
-
123
-
-
33745206550
-
Stem cell therapy for ischemic heart disease: Beginning or end of the road?
-
Stamm, C., Liebold, A., Steinhoff, G., and Strunk, D. (2006) Stem cell therapy for ischemic heart disease: beginning or end of the road? Cell. Transplant., 15: S47-56.
-
(2006)
Cell. Transplant.
, vol.15
-
-
Stamm, C.1
Liebold, A.2
Steinhoff, G.3
Strunk, D.4
-
124
-
-
0020049695
-
Stimulation of DNA synthesis in primary cultures of adult rat hepatocytes by rat platelet-associated substance(s)
-
Strain, A.J., McGowan, J.A., and Bucher, N.L. (1982) Stimulation of DNA synthesis in primary cultures of adult rat hepatocytes by rat platelet-associated substance(s). In Vitro, 18: 108-116.
-
(1982)
In Vitro
, vol.18
, pp. 108-116
-
-
Strain, A.J.1
McGowan, J.A.2
Bucher, N.L.3
-
125
-
-
9244261579
-
Adeno-associated vital vector delivers cardiac-specific and hypoxia-inducible VEGF expression in ischemic mouse hearts
-
Su, H., Joho, S., Huang, Y., Barcena, A., Arakawa-Hoyt, J., Grossman, W., and Kan, Y.W. (2004) Adeno-associated vital vector delivers cardiac-specific and hypoxia-inducible VEGF expression in ischemic mouse hearts. Proc. Natl. Acad. Sci. USA, 101: 16280-16285.
-
(2004)
Proc. Natl. Acad. Sci. USA
, vol.101
, pp. 16280-16285
-
-
Su, H.1
Joho, S.2
Huang, Y.3
Barcena, A.4
Arakawa-Hoyt, J.5
Grossman, W.6
Kan, Y.W.7
-
126
-
-
33750025357
-
AAV serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect
-
Su, H., Huang, Y., Takagawa, J., Barcena, A., Arakawa-Hoyt, J., Ye, J., Grossman, W., and Kan, Y.W. (2006) AAV serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect. Gene Ther., 13: 1495-1502.
-
(2006)
Gene Ther.
, vol.13
, pp. 1495-1502
-
-
Su, H.1
Huang, Y.2
Takagawa, J.3
Barcena, A.4
Arakawa-Hoyt, J.5
Ye, J.6
Grossman, W.7
Kan, Y.W.8
-
127
-
-
0029958320
-
Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo
-
Takeshita, S., Tsurumi, Y., Couffinahl, T., Sahara, T., Banters, C., Symes, J., Ferrara, N., and Isner, J.M. (1996) Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab. Invest., 75: 487-501.
-
(1996)
Lab. Invest.
, vol.75
, pp. 487-501
-
-
Takeshita, S.1
Tsurumi, Y.2
Couffinahl, T.3
Sahara, T.4
Banters, C.5
Symes, J.6
Ferrara, N.7
Isner, J.M.8
-
128
-
-
27744505661
-
Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector
-
Tang, Y.L., Tang, Y., Zhang, Y.C., Qian, K., Shen, L., and Phillips, M.I. (2005) Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J. Am. Coll. Cardiol., 46: 1339-1350.
-
(2005)
J. Am. Coll. Cardiol.
, vol.46
, pp. 1339-1350
-
-
Tang, Y.L.1
Tang, Y.2
Zhang, Y.C.3
Qian, K.4
Shen, L.5
Phillips, M.I.6
-
129
-
-
1642501642
-
Protection from ischemic heart injury by a vigilant heme oxygenase-1 plasmid system
-
Tang, Y.L., Tang, Y., Zhang, Y.C., Qian, K., Shen, L., and Phillips, M.I. (2004) Protection from ischemic heart injury by a vigilant heme oxygenase-1 plasmid system. Hypertension, 43:746-751.
-
(2004)
Hypertension
, vol.43
, pp. 746-751
-
-
Tang, Y.L.1
Tang, Y.2
Zhang, Y.C.3
Qian, K.4
Shen, L.5
Phillips, M.I.6
-
130
-
-
17744388581
-
Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors
-
Urbich, C., and Dimmeler, S. (2005) Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors. Kidney Int., 67: 1672-1676.
-
(2005)
Kidney Int.
, vol.67
, pp. 1672-1676
-
-
Urbich, C.1
Dimmeler, S.2
-
131
-
-
28544431828
-
Ischemic preconditioning by unstable angina reduces the release of CK-MB following CABG and stimulates left ventricular HSP-72 protein expression
-
Vahlhaus, C., Neumann, J., Luss, H., Wenzelburger, F., Tjan, T.D., Hammel, D., Scheid, H.H., Schmitz, W., Breithardt, G., and Wichter, T. (2005) Ischemic preconditioning by unstable angina reduces the release of CK-MB following CABG and stimulates left ventricular HSP-72 protein expression. J. Card. Surg., 20: 412-419.
-
(2005)
J. Card. Surg.
, vol.20
, pp. 412-419
-
-
Vahlhaus, C.1
Neumann, J.2
Luss, H.3
Wenzelburger, F.4
Tjan, T.D.5
Hammel, D.6
Scheid, H.H.7
Schmitz, W.8
Breithardt, G.9
Wichter, T.10
-
132
-
-
17644433975
-
Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease
-
Vasa, M., Fichtlscherer, S., Aicher, A., Adler, K., Urbich, C., Martin, H., Zeiher, A.M., and Dimmeler, S. (2001) Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res., 89: E1-7.
-
(2001)
Circ. Res.
, vol.89
-
-
Vasa, M.1
Fichtlscherer, S.2
Aicher, A.3
Adler, K.4
Urbich, C.5
Martin, H.6
Zeiher, A.M.7
Dimmeler, S.8
-
133
-
-
0042885512
-
Adeno-associated virus (AAV) vectors achieve prolonged transgene expression in mouse myocardium and arteries in vivo: A comparative study with adenovirus vectors
-
Vassalli, G., Bueler, H., Dudler, J., von Segesser, L.K., and Kappenberger, L. (2003) Adeno-associated virus (AAV) vectors achieve prolonged transgene expression in mouse myocardium and arteries in vivo: a comparative study with adenovirus vectors. Int. J. Cardiol., 90: 229-238.
-
(2003)
Int. J. Cardiol.
, vol.90
, pp. 229-238
-
-
Vassalli, G.1
Bueler, H.2
Dudler, J.3
von Segesser, L.K.4
Kappenberger, L.5
-
134
-
-
0034950765
-
Vascular gene transfer driven by endoglin and ICAM-2 endothelial-specific promoters
-
Velasco, B., Ramirez, J.R., Relloso, M., Li, C., Kumar, S., Lopez-Bote, J.P., Perez-Barriocanal, F., Lopez-Novoa, J.M., Cowan, P.J., d'Apice, A.J., and Bernabeu, C. (2001) Vascular gene transfer driven by endoglin and ICAM-2 endothelial-specific promoters. Gene Ther., 8: 897-904.
-
(2001)
Gene Ther.
, vol.8
, pp. 897-904
-
-
Velasco, B.1
Ramirez, J.R.2
Relloso, M.3
Li, C.4
Kumar, S.5
Lopez-Bote, J.P.6
Perez-Barriocanal, F.7
Lopez-Novoa, J.M.8
Cowan, P.J.9
d'Apice, A.J.10
Bernabeu, C.11
-
135
-
-
22244459917
-
Gene therapy: Twenty-first century medicine
-
Verma, I.M. and Weitzman, M.D. (2005) Gene therapy: twenty-first century medicine. Annu. Rev. BioChem., 74: 711-738.
-
(2005)
Annu. Rev. BioChem.
, vol.74
, pp. 711-738
-
-
Verma, I.M.1
Weitzman, M.D.2
-
136
-
-
0034739533
-
Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1alpha/VP16 hybrid transcription factor
-
Vincent, K.A., Shyu, K.G., Luo, Y., Magner, M., Tio, R.A., Jiang, C., Goldberg, M.A., Akita, G.Y., Gregory, R.J., and Isner, J.M. (2000) Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1alpha/VP16 hybrid transcription factor. Circulation, 102: 2255-2261.
-
(2000)
Circulation
, vol.102
, pp. 2255-2261
-
-
Vincent, K.A.1
Shyu, K.G.2
Luo, Y.3
Magner, M.4
Tio, R.A.5
Jiang, C.6
Goldberg, M.A.7
Akita, G.Y.8
Gregory, R.J.9
Isner, J.M.10
-
137
-
-
0036070456
-
Cardioselective overexpression of HO-1 prevents 1/R-induced cardiac dysfunction and apoptosis
-
Vulapalli, S.R., Chen, Z., Chua, B.H., Wang, T., and Liang, C.S. (2002) Cardioselective overexpression of HO-1 prevents 1/R-induced cardiac dysfunction and apoptosis. Am. J. Physiol. Heart Circ. Physiol., 283: H688-694.
-
(2002)
Am. J. Physiol. Heart Circ. Physiol.
, vol.283
-
-
Vulapalli, S.R.1
Chen, Z.2
Chua, B.H.3
Wang, T.4
Liang, C.S.5
-
138
-
-
0842264162
-
Targeted gene delivery to vascular tissue in vivo by tropism modified adeno-associated virus vectors
-
White, S.J., Nicklin, S.A., Buning, H., Brosnan, M.J., Leike, K., Papadakis, E.D., Hallek, M., and Baker, A.H. (2004) Targeted gene delivery to vascular tissue in vivo by tropism modified adeno-associated virus vectors. Circulation, 109: 513-519.
-
(2004)
Circulation
, vol.109
, pp. 513-519
-
-
White, S.J.1
Nicklin, S.A.2
Buning, H.3
Brosnan, M.J.4
Leike, K.5
Papadakis, E.D.6
Hallek, M.7
Baker, A.H.8
-
139
-
-
33745181228
-
Potential therapeutic gene for the treatment of ischemic disease: Ad2/hypoxia-inducible factor-1alpha (HIF-1)/VP16 enhances B-type natriuretic peptide gene expression via a HIF-1-responsive element
-
Wilhide, M.E., and Jones, W.K. (2006) Potential therapeutic gene for the treatment of ischemic disease: Ad2/hypoxia-inducible factor-1alpha (HIF-1)/VP16 enhances B-type natriuretic peptide gene expression via a HIF-1-responsive element. Mol. Pharmacol., 69: 1773-1778.
-
(2006)
Mol. Pharmacol.
, vol.69
, pp. 1773-1778
-
-
Wilhide, M.E.1
Jones, W.K.2
-
140
-
-
11344252479
-
Harnessing HIV for therapy, basic research and biotechnology
-
Wiznerowicz, M., and Trono, D. (2005) Harnessing HIV for therapy, basic research and biotechnology. Trends Biotechnol., 23: 42-47.
-
(2005)
Trends Biotechnol.
, vol.23
, pp. 42-47
-
-
Wiznerowicz, M.1
Trono, D.2
-
141
-
-
3042710733
-
Intra-coronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial
-
Wollert, K.C., Meyer, G.P., Lotz, J., Ringes-Lichtenberg, S., Lippolt, P., Breidenbach, C., Fichtner, S., Korte, T., Hornig, B., Messinger, D., Arseniev, L., Hertenstein, B., Ganser, A., and Drexler, H. (2004) Intra-coronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet, 364: 141-148.
-
(2004)
Lancet
, vol.364
, pp. 141-148
-
-
Wollert, K.C.1
Meyer, G.P.2
Lotz, J.3
Ringes-Lichtenberg, S.4
Lippolt, P.5
Breidenbach, C.6
Fichtner, S.7
Korte, T.8
Hornig, B.9
Messinger, D.10
Arseniev, L.11
Hertenstein, B.12
Ganser, A.13
Drexler, H.14
-
142
-
-
33746874152
-
Adeno-associated virus serotypes: Vector toolkit for human gene therapy
-
Wu, Z., Asokan, A., and Samulski, R.J. (2006) Adeno-associated virus serotypes: vector toolkit for human gene therapy. Mol. Ther., 14: 316-327.
-
(2006)
Mol. Ther.
, vol.14
, pp. 316-327
-
-
Wu, Z.1
Asokan, A.2
Samulski, R.J.3
-
143
-
-
0032924185
-
Gene therapy vectors based on adeno-associated virus type 1
-
Xiao, W., Chirmule, N., Berta, S.C., McCullough, B., Gao, G., and Wilson, J.M. (1999) Gene therapy vectors based on adeno-associated virus type 1. J. Virol., 73: 3994-4003.
-
(1999)
J. Virol.
, vol.73
, pp. 3994-4003
-
-
Xiao, W.1
Chirmule, N.2
Berta, S.C.3
McCullough, B.4
Gao, G.5
Wilson, J.M.6
-
144
-
-
0242600657
-
Genetic redox preconditioning differentially modulates AP-1 and NF kappa B responses following cardiac ischemia/reperfusion injury and protects against necrosis and apoptosis
-
Yang, J., Marden, J.J., Fan, C., Sanlioglu, S., Weiss, R.M., Ritchie, T.C., Davisson, R.L., and Engelhardt, J.F. (2003) Genetic redox preconditioning differentially modulates AP-1 and NF kappa B responses following cardiac ischemia/reperfusion injury and protects against necrosis and apoptosis. Mol. Ther., 7: 341-353.
-
(2003)
Mol. Ther.
, vol.7
, pp. 341-353
-
-
Yang, J.1
Marden, J.J.2
Fan, C.3
Sanlioglu, S.4
Weiss, R.M.5
Ritchie, T.C.6
Davisson, R.L.7
Engelhardt, J.F.8
-
145
-
-
0037968240
-
Gene transfer as a tool to induce therapeutic vascular growth
-
Yla-Herttuala, S., and Alitalo K. (2003) Gene transfer as a tool to induce therapeutic vascular growth. Nat. Med., 9: 694-701.
-
(2003)
Nat. Med.
, vol.9
, pp. 694-701
-
-
Yla-Herttuala, S.1
Alitalo, K.2
-
146
-
-
18844417604
-
Gene therapy for ischemic cardiovascular diseases: Some lessons learned from the first clinical trials
-
Yla-Herttuala, S., Markkanen, J.E., and Rissanen, T.T. (2004) Gene therapy for ischemic cardiovascular diseases: some lessons learned from the first clinical trials. Trends Cardiovasc. Med., 14: 295-300.
-
(2004)
Trends Cardiovasc. Med.
, vol.14
, pp. 295-300
-
-
Yla-Herttuala, S.1
Markkanen, J.E.2
Rissanen, T.T.3
-
147
-
-
0035957249
-
H(mox-1) constitutes an adaptive response to effect antioxidant cardioprotection: A study with transgenic mice heterozygous for targeted disruption of the Heme oxygenase-1 gene
-
Yoshida, T., Maulik, N., Ho, Y.S., Alam, J., and Das, D.K. (2001) H(mox-1) constitutes an adaptive response to effect antioxidant cardioprotection: A study with transgenic mice heterozygous for targeted disruption of the Heme oxygenase-1 gene. Circulation, 103: 1695-1701.
-
(2001)
Circulation
, vol.103
, pp. 1695-1701
-
-
Yoshida, T.1
Maulik, N.2
Ho, Y.S.3
Alam, J.4
Das, D.K.5
-
148
-
-
0034026085
-
Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer
-
Zabner, J., Seiler, M., Walters, R., Kotin, R.M., Fulgeras, W., Davidson, B.L., and Chiorini, J.A. (2000) Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer. J. Virol., 74: 3852-3858.
-
(2000)
J. Virol.
, vol.74
, pp. 3852-3858
-
-
Zabner, J.1
Seiler, M.2
Walters, R.3
Kotin, R.M.4
Fulgeras, W.5
Davidson, B.L.6
Chiorini, J.A.7
-
149
-
-
4644275138
-
HIF-1: The knowns and unknowns of hypoxia sensing
-
Zagorska, A., and Dulak, J. (2004) HIF-1: the knowns and unknowns of hypoxia sensing. Acta. Biochim. Pol., 51: 563-585.
-
(2004)
Acta. Biochim. Pol.
, vol.51
, pp. 563-585
-
-
Zagorska, A.1
Dulak, J.2
-
150
-
-
0036732734
-
Lentiviral vectors for delivery of genes into neonatal and adult ventricular cardiac myocytes in vitro and in vivo
-
Zhao, J., Pettigrew, G.J., Thomas, J., Vandenberg, J.L., Delriviere, L., Bolton, E.M., Carmichael, A., Martin, J.L., Marber, M.S., and Lever, A.M. (2002) Lentiviral vectors for delivery of genes into neonatal and adult ventricular cardiac myocytes in vitro and in vivo. Basic. Res. Cardiol., 97: 348-358.
-
(2002)
Basic. Res. Cardiol.
, vol.97
, pp. 348-358
-
-
Zhao, J.1
Pettigrew, G.J.2
Thomas, J.3
Vandenberg, J.L.4
Delriviere, L.5
Bolton, E.M.6
Carmichael, A.7
Martin, J.L.8
Marber, M.S.9
Lever, A.M.10
-
151
-
-
0037623908
-
Inhibition of myocardial injury by ischemic postconditioning during reperfusion: Comparison with ischemic preconditioning
-
Zhao, Z.Q., Corvera, J.S., Halkos, M.E., Kerendi, F., Wang, N.P., Guyton, R.A., and Vinten-Johansen, J. (2003) Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am. J. Physiol. Heart Circ. Physiol., 285: H579-88.
-
(2003)
Am. J. Physiol. Heart Circ. Physiol.
, vol.285
-
-
Zhao, Z.Q.1
Corvera, J.S.2
Halkos, M.E.3
Kerendi, F.4
Wang, N.P.5
Guyton, R.A.6
Vinten-Johansen, J.7
|